Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Panobinostat plus bortezomib/dexamethasone in relapsed or progressive multiple myeloma
CTR20140120Phase 3Completed
- Sponsor
- Tigermed
- Start
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of panobinostat in multiple myeloma (MM), sponsored by Tigermed. Started Feb 2015; status: completed.
02
Drugs
panobinostat
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on CTR20140120.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20140120.